The **liquid biopsy market** has emerged as a quintessential game changer for precision medicine, shifting the diagnostic paradigm in oncology from broad-spectrum chemotherapy to highly targeted therapies. Its core clinical utility lies in its ability to rapidly and repeatedly analyze the molecular profile of a tumor, identifying specific genetic alterations—such as mutations,...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek